Agenus (NasdaqCM:AGEN) FY Conference Transcript

Agenus (NasdaqCM:AGEN) FY Conference September 09, 2025 10:00 AM ET Speaker2Good morning, everyone. Thank you for joining us at the HC Wainwright 27th Annual Global Investment Conference. My name is Emily Bodnar. I'm an Equity Research Analyst at HC Wainwright. Pleased to be doing a fireside chat with Agenus. We have Richard Goldberg, Chief Development Officer, and Robin Taylor, Chief Commercial Officer of the company here. Maybe to start, for those a bit newer to the story, your lead asset, Botensilimab, i ...